vs
Bioventus Inc.（BVS）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是Bioventus Inc.的1.3倍（$212.2M vs $157.9M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 9.3%，领先9.4%），LiveRamp Holdings, Inc.同比增速更快（8.6% vs 2.8%），过去两年LiveRamp Holdings, Inc.的营收复合增速更高（11.1% vs 10.4%）
Bioventus Inc.是一家全球化医疗技术企业，专注于骨科生物制剂领域，研发并商业化促进骨关节愈合、肌肉骨骼疼痛管理及再生护理的相关产品，服务全球多地的骨科临床医师、康复师及患者群体。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
BVS vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.3倍
$157.9M
营收增速更快
RAMP
高出5.8%
2.8%
净利率更高
RAMP
高出9.4%
9.3%
两年增速更快
RAMP
近两年复合增速
10.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $157.9M | $212.2M |
| 净利润 | $14.8M | $39.9M |
| 毛利率 | 68.9% | 71.9% |
| 营业利润率 | 12.3% | 18.6% |
| 净利率 | 9.3% | 18.8% |
| 营收同比 | 2.8% | 8.6% |
| 净利润同比 | 3902.8% | 255.7% |
| 每股收益（稀释后） | $0.21 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BVSRAMP
| Q4 25 | $157.9M | $212.2M | ||
| Q3 25 | $138.7M | $199.8M | ||
| Q2 25 | $147.7M | $194.8M | ||
| Q1 25 | $123.9M | $188.7M | ||
| Q4 24 | $153.6M | $195.4M | ||
| Q3 24 | $139.0M | $185.5M | ||
| Q2 24 | $151.2M | $176.0M | ||
| Q1 24 | $129.5M | $171.9M |
净利润BVSRAMP
| Q4 25 | $14.8M | $39.9M | ||
| Q3 25 | $3.2M | $27.4M | ||
| Q2 25 | $7.5M | $7.7M | ||
| Q1 25 | $-2.6M | $-6.3M | ||
| Q4 24 | $-388.0K | $11.2M | ||
| Q3 24 | $-5.2M | $1.7M | ||
| Q2 24 | $-25.7M | $-7.5M | ||
| Q1 24 | $-4.9M | $-5.4M |
毛利率BVSRAMP
| Q4 25 | 68.9% | 71.9% | ||
| Q3 25 | 68.0% | 70.2% | ||
| Q2 25 | 69.1% | 70.1% | ||
| Q1 25 | 67.0% | 69.3% | ||
| Q4 24 | 66.8% | 71.9% | ||
| Q3 24 | 67.3% | 72.4% | ||
| Q2 24 | 68.5% | 70.6% | ||
| Q1 24 | 68.3% | 72.2% |
营业利润率BVSRAMP
| Q4 25 | 12.3% | 18.6% | ||
| Q3 25 | 8.1% | 10.7% | ||
| Q2 25 | 12.4% | 3.7% | ||
| Q1 25 | 3.9% | -6.1% | ||
| Q4 24 | 5.0% | 7.5% | ||
| Q3 24 | 2.6% | 4.0% | ||
| Q2 24 | -20.8% | -3.0% | ||
| Q1 24 | 3.8% | -8.3% |
净利率BVSRAMP
| Q4 25 | 9.3% | 18.8% | ||
| Q3 25 | 2.3% | 13.7% | ||
| Q2 25 | 5.1% | 4.0% | ||
| Q1 25 | -2.1% | -3.3% | ||
| Q4 24 | -0.3% | 5.7% | ||
| Q3 24 | -3.7% | 0.9% | ||
| Q2 24 | -17.0% | -4.3% | ||
| Q1 24 | -3.8% | -3.1% |
每股收益（稀释后）BVSRAMP
| Q4 25 | $0.21 | $0.62 | ||
| Q3 25 | $0.05 | $0.42 | ||
| Q2 25 | $0.11 | $0.12 | ||
| Q1 25 | $-0.04 | $-0.10 | ||
| Q4 24 | $0.00 | $0.17 | ||
| Q3 24 | $-0.08 | $0.03 | ||
| Q2 24 | $-0.40 | $-0.11 | ||
| Q1 24 | $-0.08 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $51.2M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $184.1M | $962.3M |
| 总资产 | $683.6M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BVSRAMP
| Q4 25 | $51.2M | $403.4M | ||
| Q3 25 | $42.2M | $376.9M | ||
| Q2 25 | $32.9M | $371.1M | ||
| Q1 25 | $22.8M | $420.8M | ||
| Q4 24 | $41.6M | $384.3M | ||
| Q3 24 | $43.1M | $348.4M | ||
| Q2 24 | $32.0M | $342.7M | ||
| Q1 24 | $25.2M | $368.9M |
股东权益BVSRAMP
| Q4 25 | $184.1M | $962.3M | ||
| Q3 25 | $166.1M | $943.8M | ||
| Q2 25 | $161.2M | $947.8M | ||
| Q1 25 | $148.1M | $948.9M | ||
| Q4 24 | $147.9M | $957.7M | ||
| Q3 24 | $148.7M | $932.1M | ||
| Q2 24 | $150.9M | $951.9M | ||
| Q1 24 | $171.3M | $949.1M |
总资产BVSRAMP
| Q4 25 | $683.6M | $1.3B | ||
| Q3 25 | $701.6M | $1.2B | ||
| Q2 25 | $706.8M | $1.2B | ||
| Q1 25 | $691.4M | $1.3B | ||
| Q4 24 | $728.0M | $1.3B | ||
| Q3 24 | $769.5M | $1.2B | ||
| Q2 24 | $792.2M | $1.2B | ||
| Q1 24 | $794.2M | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.0M | — |
| 自由现金流经营现金流 - 资本支出 | $37.4M | — |
| 自由现金流率自由现金流/营收 | 23.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | 0.1% |
| 现金转化率经营现金流/净利润 | 2.57× | — |
| 过去12个月自由现金流最近4个季度 | $72.1M | — |
8季度趋势，按日历期对齐
经营现金流BVSRAMP
| Q4 25 | $38.0M | — | ||
| Q3 25 | $30.1M | $57.4M | ||
| Q2 25 | $25.9M | $-15.8M | ||
| Q1 25 | $-19.3M | — | ||
| Q4 24 | $19.3M | $45.1M | ||
| Q3 24 | $10.3M | $55.6M | ||
| Q2 24 | $15.2M | $-9.3M | ||
| Q1 24 | $-6.0M | — |
自由现金流BVSRAMP
| Q4 25 | $37.4M | — | ||
| Q3 25 | $29.6M | $56.8M | ||
| Q2 25 | $25.3M | $-16.2M | ||
| Q1 25 | $-20.2M | — | ||
| Q4 24 | $18.7M | $44.8M | ||
| Q3 24 | $10.3M | $55.4M | ||
| Q2 24 | $15.1M | $-9.6M | ||
| Q1 24 | $-6.3M | — |
自由现金流率BVSRAMP
| Q4 25 | 23.7% | — | ||
| Q3 25 | 21.4% | 28.4% | ||
| Q2 25 | 17.1% | -8.3% | ||
| Q1 25 | -16.3% | — | ||
| Q4 24 | 12.2% | 22.9% | ||
| Q3 24 | 7.4% | 29.8% | ||
| Q2 24 | 10.0% | -5.4% | ||
| Q1 24 | -4.9% | — |
资本支出强度BVSRAMP
| Q4 25 | 0.4% | 0.1% | ||
| Q3 25 | 0.3% | 0.3% | ||
| Q2 25 | 0.5% | 0.2% | ||
| Q1 25 | 0.7% | 0.2% | ||
| Q4 24 | 0.4% | 0.1% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.2% | 1.0% |
现金转化率BVSRAMP
| Q4 25 | 2.57× | — | ||
| Q3 25 | 9.54× | 2.09× | ||
| Q2 25 | 3.48× | -2.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BVS
| Pain Treatments | $71.1M | 45% |
| Surgical Solutions | $48.9M | 31% |
| Restorative Therapies | $19.5M | 12% |
| Other | $18.4M | 12% |
RAMP
暂无分部数据
